The FDA announced on August 27, 2025, that Amerisource Health Services LLC is recalling chlorproMAZINE Hydrochloride Tablets, USP, 200 mg due to the presence of a foreign substance. The recall involves 873 cartons distributed nationwide.
How to tell if you have it
- Brand: Amerisource Health Services
- Product: chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton
- NDC#: 60687-463-01 (Individual Dose NDC: 60687-463-11)
- Lot codes: 1021640, Exp 10/31/2026; 1022639, Exp 01/31/2027
- Quantity: 873 cartons
The hazard
A specific lot of auxiliary polyester coil used in product packaging was detected with the presence of a micro-organism. No micro-organism was detected on any tablets.
Context
GovInfoNow's records show Amerisource Health Services LLC has 30 other recalls on record since July 27, 2022. Other recent recalls of similar products include Amerisource Health Primidone Tablets Recall (May 1, 2026), Meclizine 12.5mg Tablets Recall (March 16, 2026), and Oxycodone 5mg Tablets Recall (January 14, 2026). Other recent recalls of similar products include Golden State Baclofen Tablets Recall (November 26, 2025), Amgen Recalls Corlanor 5mg Tablets Due to Foreign Substance (June 4, 2026), and Bionpharma Divalproex Tablets Recall (June 26, 2026).